Document is current
Any future updates will be listed below
-
Authors
van Karnebeek, Clara D. M. https://orcid.org/0000-0002-2648-8337
O’Donnell-Luria, Anne
Baynam, Gareth
Baudot, Anaïs
Groza, Tudor
Jans, Judith J. M.
Lassmann, Timo
Letinturier, Mary Catherine V.
Montgomery, Stephen B.
Robinson, Peter N.
Sansen, Stefaan
Mehrian-Shai, Ruty
Steward, Charles
Kosaki, Kenjiro
Durao, Patricia
Sadikovic, Bekim
-
Funding
Funding for this research was provided by:
Horizon 2020 Framework Programme (825575)
Feilman Foundation (Channel 7 Telethon Trust)
Stan Perron Charitable Foundation (Channel 7 Telethon Trust)
National Human Genome Research Institute (U01HG011762, U01HG011755)
The McCusker Charitable Foundation (Channel 7 Telethon Trust)
- License Information
-
More Information
Article History
Received: 26 March 2024
Accepted: 11 September 2024
First Online: 27 September 2024
Declarations
:
: The study does not involve human data or human tissue. No ethics approval was required.
: The study does not contain any individual person’s data.
: CVK, AB, PD, TG, JJ, KK, TL, MCVL, PNR, RS, and GB declare no competing interests. BS is a cofounder of EpiSign Inc., a software biotech company. AODL is a scientific advisor for Tome Biosciences and Congenica Inc. SBM is an advisor for BioMarin, MyOme and Tenaya Therapeutics. SS is an employee of Sanofi. CS is an employee of Genomics England.
